Infusing New Life Into Life Sciences

Life sciences facilities need to balance speed, quality, cost and technical complexity — all while adhering to regulations — to remain competitive in one of the fastest growing
global economy sectors.

Constructing a Healthier World

We create modern spaces for medical and scientific advancement. We design and build facilities and processes that help improve human and animal lives through the creation of products in the life sciences space. From research and ideation to accelerated commercialization, manufacturing, design, construction and environmental compliance, we help clients solve complex problems. Our true value is our ability to capture the entire project picture and integrate the highly technical and detailed engineering required for these spaces with constructability and cost controls.

Rethinking Production Operations

Pharmaceuticals, biologics, medical devices, cell and gene therapy, animal health and nutritional products improve health and quality of life and are all part of the life sciences industry. Through sustainable and integrated design-build delivery, we partner with companies across the life sciences spectrum to develop the high-performance, high-capacity facilities and manufacturing processes needed for the next generation of sustainable operations.

CLICK TO ENLARGE

Life Sciences Project Experience

Life Sciences Services

Integrated design-build is about streamlining processes from facility conception to completion. Our pathway from discoveries to manufacturing consumer products has safety and quality built into each step along the way: research and development, clinical trials, pilot scale production, bulk API production, formulation/filling and packaging distribution.

Our innovative solutions are designed to reduce costs, accelerate schedules and optimize production:

• Site selection
• Master planning
• Process engineering
• Automation engineering
• Instrumentation and controls
• Environmental engineering
• Utilities
• Facility evaluation
• Facility design
• Design-build
• Commissioning and startup

Building Facilities for the Future

The most critical aspects of a life sciences facility are meeting the project owner’s intent and developing effective processes that allow for quality products to quickly get to market. That all starts with future-centric design. Shortened timelines, environmental accountability, advances in automation and a commitment to quality drive strategic product development and efficiency. We can help navigate it all and optimize performance with a well-planned, organized approach custom fit for your needs.

---

Related Content

Blog

Discontinued PFAS-Containing Heat Transfer Fluids Impact Pharmaceutical Manufacturing

Burns & McDonnell

With PFAS regulations finalized, the pharmaceutical industry is looking for solutions. Discontinued heat transfer fluids pose a challenge.

Blog

Trends Advancing Life Sciences Development

Burns & McDonnell

There are key trends shaping the future of the life sciences industry: flexible manufacturing, speed to market, and advanced technology, including artificial intelligence.

Article

Scoping Out Solutions for Supply Chain and Labor Challenges

Burns & McDonnell

Sometimes challenges contain the seeds of their own solutions. Bogged-down supply chains and persistent shortages of skilled labor are familiar complications throughout many industries, but efforts to address them are also driving more efficiencies in project planning and execution.

Service Feature

Integrating Robotics Into Existing Processes

Burns & McDonnell

Industrial automation through robotics is more accessible than ever with robots performing human-like functions such as assembling and testing products and picking and packaging them for distribution. Consider integrating this competitive advantage into your process to reap the safe, fast and reliable rewards.

White Paper

Office to Lab Conversions: A Greener Approach

Burns & McDonnell

With many employers and workplaces still navigating how to pivot in the face of the rise of remote working, commercial property owners and landlords are looking to a new solution to use vacant office space. The potential to accommodate life science uses is one solution being explored.

White Paper

Anticipated New Phase In U.S. Manufacturing

Burns & McDonnell

With the COVID-19 crisis, global insecurities have never been more apparent and are leading to a push to onshore pharmaceutical manufacturing.

Blog

Four Opportunities to Diversify API Manufacturing

Burns & McDonnell

Supply chain diversification for active pharmaceutical ingredient (API) manufacturing is one way to restore reliability in medication production.

Case Study

Manufacturer Seeks Guidance for nCGMP Facility Search

Burns & McDonnell

This confidential client needed a 500,000-square-foot new current good manufacturing practices (nCGMP) facility for its expanding operations. The manufacturer was seeking a location with room for current employees and manufacturing equipment, plus space for future growth.

Blog

Automating Pharmaceutical Inspections for Efficient Delivery

Burns & McDonnell

By automating previously manual pharmaceutical inspections, the life sciences industry takes a step toward maintaining safe and reliable production.

Blog

Powering Future Manufacturing With Decarbonized Industrial Operations

Burns & McDonnell

Industrial manufacturers are exploring how to decarbonize assets and processes, a key step in reducing greenhouse gas emissions and promoting sustainability.

White Paper

The Transformation Taking Place in Life Sciences Facility Development

Burns & McDonnell

Drug and medical technology breakthroughs, data management and integration opportunities, and a growing body of research are pushing the life sciences industry forward at an ever-faster pace. This rapid growth is impacting the facilities constructed by major pharmaceutical companies, drug discovery companies and contract manufacturers in different ways.

White Paper

Reducing Bioaerosol Risks at Pharmaceutical Plants

Burns & McDonnell

More than 45 years after the first known outbreak of Legionnaires’ disease was linked to tiny, airborne droplets emitted by a cooling tower, such bioaerosols containing bacteria, viruses, fungi and other microbes continue to pose health risks to people who live and work nearby. A fresh look at pharmaceutical plant design can help to change that.

LOAD MORE  

---